Phenylketonuria (PKU) is a rare inherited metabolic condition caused by a lack of the enzyme phenylalanine hydroxylase (PAH). This leads to a buildup of the amino acid Phe, which impacts the brain, if not managed through a low-protein diet.

Learn more about our active PKU clinical trials below. To view all BioMarin’s historical trials in PKU, click here.